We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Merit Medical Systems Inc | NASDAQ:MMSI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.95 | 2.53% | 78.97 | 59.00 | 80.70 | 79.11 | 76.95 | 77.22 | 263,070 | 05:00:03 |
| 1. Name and Address of Reporting Person * STANGER KENT W | 2. Issuer Name and Ticker or Trading SymbolMERIT MEDICAL SYSTEMS INC [MMSI] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
| 3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) | ||
| 4. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form Filed by One Reporting Person ___ Form Filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
| 1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any | 3. Trans. Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Amount | (A) or (D) | Price | ||||||||
| Common Stock, No Par Value | 42278 | I | By 401(k) plan (1) | |||||||
| Common Stock, No Par Value | 4271 (2) | D | ||||||||
| Common Stock, No Par Value | 29524 | I | Family Limited Liability Company (3) | |||||||
| Common Stock, No Par Value | 10/30/2019 | G (4) | 2769 | D | $0 | 412318 | D | |||
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
| 1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (MM/DD/YYYY) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||||
| Non-qualified stock options (right to buy) | $12.06 | 10/4/2015 (5) | 10/4/2021 | Common Stock | 2000 | 2000 | D | ||||||||
| Non-qualified stock options (right to buy) | $19.72 | 5/2/2017 (6) | 5/2/2023 | Common Stock | 9375 | 9375 | D | ||||||||
| Non-qualified stock options (right to buy) | $18.80 | 5/26/2017 (7) | 5/26/2023 | Common Stock | 25000 | 25000 | D | ||||||||
| Non-qualified stock options (right to buy) | $34.4 | 5/24/2018 (8) | 5/24/2024 | Common Stock | 25000 | 25000 | D | ||||||||
| Non-qualified stock options (right to buy) | $50.5 | 6/7/2019 (9) | 6/7/2025 | Common Stock | 25000 | 25000 | D | ||||||||
| Non-qualified stock options (right to buy) | $52.17 | 5/24/2020 (10) | 5/24/2026 | Common Stock | 13750 | 13750 | D | ||||||||
| Non-qualified stock options (right to buy) | $52.17 | 5/31/2020 (11) | 5/31/2026 | Common Stock | 7500 | 7500 | D | ||||||||
| Reporting Owners | |||||
| Reporting Owner Name / Address | |||||
| Director | 10% Owner | Officer | Other | ||
| STANGER KENT W 1600 W MERIT PARKWAY SOUTH JORDAN, UT 84095 | X | ||||
| Signatures | ||
| Brian G. Lloyd, Attorney-in-Fact | 1/23/2020 | |
| **Signature of Reporting Person | Date | |
1 Year Merit Medical Systems Chart |
1 Month Merit Medical Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
